Clinical Challenges: EGFR-Mutated NSCLC

(MedPage Today) -- Epidermal growth factor receptor (EGFR) mutations are seen in approximately 10-20% of patients with non-small cell lung cancer (NSCLC), with a higher percentage observed among Asian patients. But considering that over 200,000...